Retour
Fourchette du Jour
86,34 €
89,74 €
Fourchette 52 Semaines
81,36 €
118,30 €
Volume
784 556
Moyenne 50J / 200J
100,54 €
/
95,51 €
Clôture Précédente
87,46 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 40,6 | 0,3 |
| P/B | 1,4 | 3,0 |
| ROE % | 3,2 | 3,7 |
| Net Margin % | 8,5 | 3,8 |
| Rev Growth 5Y % | -7,1 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
115,14 €
+31.1%
Low: 105,00 €
High: 129,00 €
P/E Prévisionnel
16,14
BPA Prévisionnel
5,40 €
Croissance BPA (est.)
+0,0%
CA Est.
2,98B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
7,91 €
7,84 € – 8,01 €
|
3,68B | 1 |
| FY2029 |
7,16 €
7,09 € – 7,24 €
|
3,48B | 1 |
| FY2028 |
6,54 €
5,32 € – 7,76 €
|
3,30B | 2 |
No quarterly estimates available
Dividend History
7 yr streakYield
0,00%
Payout Ratio
0,14%
Growth (3Y)
0,00%
Growth (5Y)
0,00%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 17, 2026 | May 08, 2026 | 0,07 € | 0,32% |
| Jan 16, 2026 | Feb 06, 2026 | 0,07 € | 0,25% |
| Oct 17, 2025 | Nov 07, 2025 | 0,07 € | 0,30% |
| Jul 18, 2025 | Aug 08, 2025 | 0,07 € | 0,30% |
| Apr 17, 2025 | May 09, 2025 | 0,07 € | 0,30% |
| Jan 17, 2025 | Feb 07, 2025 | 0,07 € | 0,24% |
| Oct 18, 2024 | Nov 08, 2024 | 0,07 € | 0,23% |
| Jul 19, 2024 | Aug 09, 2024 | 0,07 € | 0,26% |
| Apr 18, 2024 | May 10, 2024 | 0,07 € | 0,28% |
| Jan 18, 2024 | Feb 09, 2024 | 0,07 € | 0,26% |
| Oct 19, 2023 | Nov 10, 2023 | 0,07 € | 0,28% |
| Jul 20, 2023 | Aug 11, 2023 | 0,07 € | 0,22% |
| Apr 20, 2023 | May 12, 2023 | 0,07 € | 0,21% |
| Jan 19, 2023 | Feb 10, 2023 | 0,07 € | 0,21% |
| Oct 20, 2022 | Nov 11, 2022 | 0,07 € | 0,22% |
| Jul 21, 2022 | Aug 12, 2022 | 0,07 € | 0,19% |
| Apr 21, 2022 | May 13, 2022 | 0,07 € | 0,18% |
| Jan 20, 2022 | Feb 11, 2022 | 0,07 € | 0,16% |
| Oct 21, 2021 | Nov 12, 2021 | 0,07 € | 0,16% |
| Jul 15, 2021 | Aug 06, 2021 | 0,07 € | 0,18% |
Points Clés
Revenue declined -7,06% annually over 5 years
Earnings declined -18,31% over the past year
ROE of 3,24% is below average
Debt/Equity of 0,48 — conservative balance sheet
Generating 508,26M in free cash flow
P/E of 40,64 — premium valuation
Croissance
Revenue Growth (5Y)
-7,06%
Revenue (1Y)3,67%
Earnings (1Y)-18,31%
FCF Growth (3Y)616,37%
Qualité
Return on Equity
3,24%
ROIC2,48%
Net Margin8,46%
Op. Margin12,49%
Sécurité
Debt / Equity
0,48
Current Ratio1,68
Interest Coverage3,87
Valorisation
P/E Ratio
40,64
Forward P/E16,14
P/B Ratio1,35
EV/EBITDA34,82
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,67% | Revenue Growth (3Y) | 1,90% |
| Earnings Growth (1Y) | -18,31% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -7,06% | Earnings Growth (5Y) | -28,85% |
| Profitability | |||
| Revenue (TTM) | 2,86B | Net Income (TTM) | 241,68M |
| ROE | 3,24% | ROA | 1,99% |
| Gross Margin | 53,08% | Operating Margin | 12,49% |
| Net Margin | 8,46% | Free Cash Flow (TTM) | 508,26M |
| ROIC | 2,48% | FCF Growth (3Y) | 616,37% |
| Safety | |||
| Debt / Equity | 0,48 | Current Ratio | 1,68 |
| Interest Coverage | 3,87 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,14% |
| Dividend Growth (3Y) | 0,00% | Dividend Growth (5Y) | 0,00% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 40,64 | Forward P/E | 16,14 |
| P/B Ratio | 1,35 | P/S Ratio | 3,44 |
| PEG Ratio | -3,32 | Forward PEG | N/A |
| EV/EBITDA | 34,82 | Fwd EV/EBITDA | 13,22 |
| Forward P/S | 3,30 | Fwd Earnings Yield | 6,20% |
| FCF Yield | 5,18% | ||
| Market Cap | 9,82B | Enterprise Value | 12,42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,86B | 2,76B | 2,75B | 3,31B | 3,83B |
| Net Income | 241,68M | 295,83M | -118,38M | 569,18M | 943,16M |
| EPS (Diluted) | 2,08 | 2,41 | -0,95 | 4,50 | 8,08 |
| Gross Profit | 1,52B | 1,32B | 1,32B | 1,76B | 2,28B |
| Operating Income | 356,64M | 410,52M | 399,49M | 781,12M | 1,34B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,17B | 12,39B | 13,56B | 14,13B | 15,00B |
| Total Liabilities | 4,92B | 4,73B | 5,69B | 6,75B | 7,86B |
| Shareholders' Equity | 7,25B | 7,67B | 7,87B | 7,38B | 7,14B |
| Total Debt | 3,52B | 3,33B | 4,07B | 4,60B | 5,16B |
| Cash & Equivalents | 919,87M | 1,16B | 913,16M | 454,36M | 603,32M |
| Current Assets | 2,24B | 2,35B | 3,00B | 3,29B | 2,44B |
| Current Liabilities | 1,33B | 653,10M | 1,45B | 1,54B | 1,21B |